Obesity and the heart;Obesidad y corazón

Revista Espanola de Cardiologia

Volumn 64, Issue 2, 2011, Pages 140-149

  López Jiménez, Francisco ^a   Cortés Bergoderi, Mery ^a  

^a MAYO CLINIC   (United States)

Author keywords

Bariatric surgery; Body mass index; Coronary artery disease; Obesity

Indexed keywords

ARTICLE; BARIATRIC SURGERY; BODY FAT; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DYSLIPIDEMIA; HEART; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT SAFETY; PROGNOSIS; THERAPY EFFECT; BODY COMPOSITION; BODY WEIGHT; HEART DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SLEEP APNEA SYNDROME;

BARIATRIC SURGERY; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; HEART DISEASES; HUMANS; OBESITY; SLEEP APNEA, OBSTRUCTIVE;

EID: 79951725334     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2010.10.010     Document Type: Article

References (94)

1. F. López-Jiménez, S.J. Jacobsen, G.S. Reeder, S.A. Weston, R.A. Meverden, and V.L. Roger Prevalence and secular trends of excess body weight and impact on outcomes after myocardial infarction in the community Chest. 125 2004 1205 1212
2. V.A. Catenacci, J.O. Hill, and H.R. Wyatt The obesity epidemic Clin Chest Med. 30 2009 415 444
3. OECD Press Release 2010: Health: OECD says government must fight fat. Disponible en: http://www.oecd.org/document/35/0,3343,en-21571361-44315115- 46064099-1-1-1-1,00.html
4. P. Poirier Cardiologists and abdominal obesity: lost in translation? Heart. 95 2009 1033 1035
5. P. Poirier, T.D. Giles, G.A. Bray, Y. Hong, J.S. Stern, and F.X. Pi-Sunyer Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism Circulation. 113 2006 898 918
6. K. Narkiewicz, J. Wolf, F. López-Jiménez, and V.K. Somers Obstructive sleep apnea and hypertension Curr Cardiol Rep. 7 2005 435 440
7. A. Romero-Corral, V.M. Montori, V.K. Somers, J. Korinek, R.J. Thomas, and T.G. Allison Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies Lancet. 368 2006 666 678
8. J. Sierra-Johnson, A. Romero-Corral, and F. López-Jiménez Utility of different lipid measures to predict coronary heart disease JAMA. 299 2008 235
9. A. Romero-Corral, J. Sierra-Johnson, F. López-Jiménez, R.J. Thomas, P. Singh, and M. Hoffmann Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population Nat Clin Pract. 5 2008 418 425
10. N. Chaowalit, and F. López-Jiménez Epicardial adipose tissue: friendly companion or hazardous neighbour for adjacent coronary arteries? Eur Heart J. 29 2008 695 697
11. J.A. Batsis, R.E. Nieto-Martínez, and F. López- Jiménez Metabolic syndrome: from global epidemiology to individualized medicine Clin Pharmacol Ther. 82 2007 509 524
12. J.P. Despres, and I. Lemieux Abdominal obesity and metabolic syndrome Nature. 444 2006 881 887
13. J. Sierra-Johnson, A. Romero-Corral, V.K. Somers, F. López- Jiménez, A. Malarstig, and K. Brismar IGF-I/IGFBP-3 ratio: a mechanistic insight into the metabolic syndrome Clin Sci (Lond). 116 2009 507 512
14. J. Sierra-Johnson, A. Romero-Corral, F. López-Jiménez, A.S. Gami, F.H. Sert Kuniyoshi, and R. Wolk Relation of increased leptin concentrations to history of myocardial infarction and stroke in the United States population Am J Cardiol. 100 2007 234 239
15. U. Scherrer, D. Randin, L. Tappy, P. Vollenweider, E. Jequier, and P. Nicod Body fat and sympathetic nerve activity in healthy subjects Circulation. 89 1994 2634 2640
16. G. Grassi, G. Seravalle, D.A. Calhoun, and G. Mancia Physical training and baroreceptor control of sympathetic nerve activity in humans Hypertension. 23 1994 294 301
17. G.A. Bray, D.A. York, and J.S. Fisler Experimental obesity: a homeostatic failure due to defective nutrient stimulation of the sympathetic nervous system Vitam Horm. 45 1989 1 125
18. A.N. Vgontzas, T.L. Tan, E.O. Bixler, L.F. Martin, D. Shubert, and A. Kales Sleep apnea and sleep disruption in obese patients Arch Intern Med. 154 1994 1705 1711
19. M. Vaz, G. Jennings, A. Turner, H. Cox, G. Lambert, and M. Esler Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects Circulation. 96 1997 3423 3429
20. J. Sundell, H. Laine, M. Luotolahti, K. Kalliokoski, O. Raitakari, and P. Nuutila Obesity affects myocardial vasoreactivity and coronary flow response to insulin Obes Res. 10 2002 617 624
21. J.R. Vane, E.E. Anggard, and R.M. Botting Regulatory functions of the vascular endothelium N Engl J Med. 323 1990 27 36
22. R. Bergholm, M. Tiikkainen, S. Vehkavaara, M. Tamminen, K. Teramo, and A. Rissanen Lowering of LDL cholesterol rather than moderate weight loss improves endothelium-dependent vasodilatation in obese women with previous gestational diabetes Diabetes Care. 26 2003 1667 1672
23. S. Sasaki, Y. Higashi, K. Nakagawa, M. Kimura, K. Noma, and S. Sasaki A low-calorie diet improves endothelium-dependent vasodilation in obese patients with essential hypertension Am J Hypertens. 15 2002 302 309
24. W.K. Lagrand, C.A. Visser, W.T. Hermens, H.W. Niessen, F.W. Verheugt, and G.J. Wolbink C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation. 100 1999 96 102
25. L.H. Kuller, R.P. Tracy, J. Shaten, and E.N. Meilahn Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial Am J Epidemiol. 144 1996 537 547
26. P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, and C.H. Hennekens Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med. 336 1997 973 979
27. A.E. Hak, C.D. Stehouwer, M.L. Bots, K.H. Polderman, C.G. Schalkwijk, and I.C. Westendorp Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women Arterioscler Thromb Vasc Biol. 19 1999 1986 1991
28. J.P. Bastard, C. Jardel, J. Delattre, B. Hainque, E. Bruckert, and F. Oberlin Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects Circulation. 99 1999 2221 2222
29. A. Tchernof, A. Nolan, C.K. Sites, P.A. Ades, and E.T. Poehlman Weight loss reduces C-reactive protein levels in obese postmenopausal women Circulation. 105 2002 564 569
30. P. Ziccardi, F. Nappo, G. Giugliano, K. Esposito, R. Marfella, and M. Cioffi Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year Circulation. 105 2002 804 809
31. G. Avellone, V. Di Garbo, R. Cordova, G. Cucinella, R. De Simone, and G. Raneli Evaluation of cardiovascular risk factors in overweight and obese subjects Int Angiol. 13 1994 25 29
32. G. Licata, R. Scaglione, G. Avellone, A. Ganguzza, S. Corrao, and S. Arnone Hemostatic function in young subjects with central obesity: relationship with left ventricular function Metabolism. 44 1995 1417 1421
33. M. Margaglione, G. Cappucci, M. D'Addedda, D. Colaizzo, N. Giuliani, and G. Vecchione PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants Arterioscler Thromb Vasc Biol. 18 1998 562 567 (Pubitemid 28177895)
34. M. Eliasson, M.E. Roder, B. Dinesen, P.E. Evrin, and B. Lindahl Proinsulin, intact insulin, and fibrinolytic variables and fibrinogen in healthy subjects. A population study Diabetes Care. 20 1997 1252 1255
35. A. Festa, L. Mykkanen, R.P. Tracy, D.J. Zaccaro, and C.N. Hales Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS) Arterioscler Thromb Vasc Biol. 19 1999 2 568
36. M.C. Alessi, F. Peiretti, P. Morange, M. Henry, G. Nalbone, and I. Juhan-Vague Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease Diabetes. 46 1997 860 867
37. P. Eriksson, V. Van Harmelen, J. Hoffstedt, P. Lundquist, H. Vidal, and V. Stemme Regional variation in plasminogen activator inhibitor-1 expression in adipose tissue from obese individuals Thromb Haemost. 83 2000 545 548 (Pubitemid 30201128)
38. N. Chaowalit, V.K. Somers, P.A. Pellikka, C.S. Rihal, and F. López-Jiménez Subepicardial adipose tissue and the presence and severity of coronary artery disease Atherosclerosis. 186 2006 354 359
39. J.M. Marchington, C.A. Mattacks, and C.M. Pond Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties Comp Biochem Physiol. 94 1989 225 232
40. J.M. Marchington, and C.M. Pond Site-specific properties of pericardial and epicardial adipose tissue: the effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vitro Int J Obes. 14 1990 1013 1022
41. T. Mazurek, L. Zhang, A. Zalewski, J.D. Mannion, J.T. Diehl, and H. Arafat Human epicardial adipose tissue is a source of inflammatory mediators Circulation. 108 2003 2460 2466
42. N. Chaowalit, V.K. Somers, P.A. Pellikka, C.S. Rihal, and F. López-Jiménez Adipose tissue of atrial septum as a marker of coronary artery disease Chest. 132 2007 817 822
43. G. Iacobellis, F. Assael, M.C. Ribaudo, A. Zappaterreno, G. Alessi, and U. Di Mario Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction Obes Res. 11 2003 304 310
44. G. Iacobellis, and F. Leonetti Epicardial adipose tissue and insulin resistance in obese subjects J Clin Endocrinol Metab. 90 2005 6300 6302
45. G. Iacobellis, M.C. Ribaudo, F. Assael, E. Vecci, C. Tiberti, and A. Zappaterreno Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk J Clin Endocrinol Metab. 88 2003 5163 5168
46. G. Iacobellis, M.C. Ribaudo, A. Zappaterreno, C.V. Iannucci, and F. Leonetti Relation between epicardial adipose tissue and left ventricular mass Am J Cardiol. 94 2004 1084 1087
47. R. Taguchi, J. Takasu, Y. Itani, R. Yamamoto, K. Yokoyama, and S. Watanabe Pericardial fat accumulation in men as a risk factor for coronary artery disease Atherosclerosis. 157 2001 203 209
48. A.M. De Vos, M. Prokop, C.J. Roos, M.F. Meijs, Y.T. Van der Schouw, and A. Rutten Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women Eur Heart J. 29 2008 777 783
49. A. Malhotra, and D.P. White Obstructive sleep apnoea Lancet. 360 2002 237 245
50. F. López-Jiménez, F.H. Sert Kuniyoshi, A. Gami, and V.K. Somers Obstructive sleep apnea: implications for cardiac and vascular disease Chest. 133 2008 793 804
51. T. Konecny, F.H. Kuniyoshi, M. Orban, G.S. Pressman, T. Kara, and A. Gami Under-diagnosis of sleep apnea in patients after acute myocardial infarction J Am Coll Cardiol. 56 2010 742 743
52. E. Shahar, C.W. Whitney, S. Redline, E.T. Lee, A.B. Newman, and F. Javier Nieto Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study Am J Respir Crit Care Med. 163 2001 19 25 (Pubitemid 32095247)
53. J.M. Marín, S.J. Carrizo, E. Vicente, and A.G. Agusti Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study Lancet. 365 2005 1046 1053
54. F. López-Jiménez, C.O. Wu, X. Tian, C. O'Connor, M.W. Rich, and M.M. Burg Weight change after myocardial infarction - the Enhancing Recovery in Coronary Heart Disease patients (ENRICHD) experience Am Heart J. 155 2008 478 484
55. A. Bardia, S.G. Holtan, J.M. Slezak, and W.G. Thompson Diagnosis of obesity by primary care physicians and impact on obesity management Mayo Clin Proc. 82 2007 927 932
56. S. Singh, and F. López-Jiménez Medically diagnosed overweight and weight loss in a US national survey Prev Med. 51 2010 24 26
57. F. López-Jiménez, M. Malinski, M. Gutt, J. Sierra-Johnson, Y. Wady Aude, and A.A. Rimawi Recognition, diagnosis and management of obesity after myocardial infarction Int J Obes. 29 2005 137 141
58. Y.W. Aude, A.S. Agatston, F. López-Jiménez, E.H. Lieberman, A. Marie, and M. Hansen The National Cholesterol Education Program diet vs a diet lower in carbohydrates and higher in protein and monounsaturated fat: a randomized trial Arch Intern Med. 164 2004 2141 2146
59. P.Y. Scarabin, A.M. Vissac, J.M. Kirzin, P. Bourgeat, J. Amiral, and R. Agher Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII Arterioscler Thromb Vasc Biol. 16 1996 1170 1176
60. S. Kenchaiah, J.C. Evans, D. Levy, P.W. Wilson, E.J. Benjamin, and M.G. Larson Obesity and the risk of heart failure N Engl J Med. 347 2002 305 313
61. H. Krum, and W.T. Abraham Heart failure Lancet. 373 2009 941 955
62. C.Y. Wong, T. O'Moore-Sullivan, R. Leano, N. Byrne, E. Beller, and T.H. Marwick Alterations of left ventricular myocardial characteristics associated with obesity Circulation. 110 2004 3081 3087
63. K.H. Amad, J.C. Brennan, and J.K. Alexander The cardiac pathology of chronic exogenous obesity Circulation. 32 1965 740 745
64. B.D. Powell, M.M. Redfield, K.A. Bybee, W.K. Freeman, and C.S. Rihal Association of obesity with left ventricular remodeling and diastolic dysfunction in patients without coronary artery disease Am J Cardiol. 98 2006 116 120
65. T.J. Wang, H. Parise, D. Levy, P.A. Wolf, and R.S. Vasan Obesity and the risk of new-onset atrial fibrillation JAMA. 292 2004 2471 2477
66. N. Wanahita, F.H. Messerli, S. Bangalore, A.S. Gami, V.K. Somers, and J.S. Steinberg Atrial fibrillation and obesity - results of a meta-analysis Am Heart J. 155 2008 310 315
67. F.H. Messerli, B.D. Núñez, H.O. Ventura, and D.W. Snyder Overweight and sudden death. Increased ventricular ectopy in cardiopathy of obesity Arch Intern Med. 147 1987 1725 1728
68. A. El-Gamal, D. Gallagher, A. Nawras, P. Gandhi, J. Gomez, and D.B. Allison Effects of obesity on QT, RR, and QTc intervals Am J Cardiol. 75 1995 956 959
69. B. Aijaz, K.A. Ammar, F. López-Jiménez, M.M. Redfield, S.J. Jacobsen, and R.J. Rodeheffer Abnormal cardiac structure and function in the metabolic syndrome: a population-based study Mayo Clin Proc. 83 2008 1350 1357
70. C.J. Lavie, R.V. Milani, and H.O. Ventura Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss J Am Coll Cardiol. 53 2009 1925 1932
71. G.K. Andrikopoulos, D.J. Richter, P.E. Dilaveris, A. Pipilis, A. Zaharoulis, and J.E. Gialafos In-hospital mortality of habitual cigarette smokers after acute myocardial infarction; the "smoker's paradox" in a countrywide study Eur Heart J. 22 2001 776 784
72. S.G. Gourlay, A.C. Rundle, and H.V. Barron Smoking and mortality following acute myocardial infarction: results from the National Registry of Myocardial Infarction 2 (NRMI 2) Nicotine Tob Res. 4 2002 101 107
73. B.G. Angeja, S. Kermgard, M.S. Chen, M. McKay, S.A. Murphy, and E.M. Antman The smoker's paradox: insights from the angiographic substudies of the TIMI trials J Thromb Thrombolysis. 13 2002 133 139
74. G. Weisz, D.A. Cox, E. García, J.E. Tcheng, J.J. Griffin, and G. Guagliumi Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction - the smoker's paradox revisited Am Heart J. 150 2005 358 364 (Pubitemid 41116264)
75. J. Sierra-Johnson, S.R. Wright, F. López-Jiménez, and T.G. Allison Relation of body mass index to fatal and nonfatal cardiovascular events after cardiac rehabilitation Am J Cardiol. 96 2005 211 214
76. F. Lauretani, C.R. Russo, S. Bandinelli, B. Bartali, C. Cavazzini, and A. Di Iorio Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia J Appl Physiol. 95 2003 1851 1860
77. A. Romero-Corral, V.K. Somers, J. Sierra-Johnson, M.D. Jensen, R.J. Thomas, and R.W. Squires Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease Eur Heart J. 28 2007 2087 2093
78. A. Romero-Corral, V.K. Somers, J. Sierra-Johnson, R.J. Thomas, M.L. Collazo-Clavell, and J. Korinek Accuracy of body mass index in diagnosing obesity in the adult general population Int J Obes (Lond). 32 2008 959 966
79. Metropolitan Life Insurance Company. Overweight: its prevention and significance. Stat Bull Metropol Life Insur Co. 1960; 41:6.
80. L.A. Quetelet A treatise on man and the development of his faculties. 1842 Obes Res. 2 1994 72 85
81. WHO. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. 1995 Technical Report Series No. 854. Disponible en: http://www.who.int/childgrowth/publications/physical-status/en/index.html
82. D.O. Okorodudu, M.F. Jumean, V.M. Montori, A. Romero-Corral, V.K. Somers, and P.J. Erwin Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis Int J Obes (Lond). 34 2010 791 799
83. M. Fogelholm, and W. Van Marken Lichtenbelt Comparison of body composition methods: a literature analysis Eur J Clin Nutr. 51 1997 495 503
84. A. Romero-Corral, V.K. Somers, J. Sierra-Johnson, Y. Korenfeld, S. Boarin, and J. Korinek Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality Eur Heart J. 31 2010 737 746
85. D.C. Lau, J.D. Douketis, K.M. Morrison, I.M. Hramiak, A.M. Sharma, and E. Ur Obesity Canada Clinical Practice Guidelines Expert Panel. 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children CMAJ. 176 2007 S1 S13
86. D. Rucker, R. Padwal, S.K. Li, C. Curioni, and D.C. Lau Long term pharmacotherapy for obesity and overweight: updated meta-analysis BMJ. 335 2007 1194 1199
87. F. López-Jiménez, S. Bhatia, M.L. Collazo-Clavell, M.G. Sarr, and V.K. Somers Safety and efficacy of bariatric surgery in patients with coronary artery disease Mayo Clin Proc. 80 2005 1157 1162
88. J.J. Gleysteen, J.J. Barboriak, and E.A. Sasse Sustained coronary-risk-factor reduction after gastric bypass for morbid obesity Am J Clin Nutr. 51 1990 774 778
89. J.L. Carson, M.E. Ruddy, A.E. Duff, N.J. Holmes, R.P. Cody, and R.E. Brolin The effect of gastric bypass surgery on hypertension in morbidly obese patients Arch Intern Med. 154 1994 193 200
90. J.A. Batsis, A. Romero-Corral, M.L. Collazo-Clavell, M.G. Sarr, V.K. Somers, and F. López-Jiménez Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study Mayo Clin Proc. 83 2008 897 907
91. J.A. Batsis, M.G. Sarr, M.L. Collazo-Clavell, R.J. Thomas, A. Romero-Corral, and V.K. Somers Cardiovascular risk after bariatric surgery for obesity Am J Cardiol. 102 2008 930 937
92. C.A. Garza, P.A. Pellikka, V.K. Somers, M.G. Sarr, M.L. Collazo-Clavell, and Y. Korenfeld Structural and functional changes in left and right ventricles after major weight loss following bariatric surgery for morbid obesity Am J Cardiol. 105 2010 550 556
93. C.A. Garza, P.A. Pellikka, V.K. Somers, M.G. Sarr, J.B. Seward, and M.L. Collazo-Clavell Major weight loss prevents long-term left atrial enlargement in patients with morbid and extreme obesity Eur J Echocardiogr. 9 2008 587 593
94. J.A. Batsis, A. Romero-Corral, M.L. Collazo-Clavell, M.G. Sarr, V.K. Somers, and L. Brekke Effect of weight loss on predicted cardiovascular risk: change in cardiac risk after bariatric surgery Obesity (Silver Spring). 15 2007 772 784